NITROPRUSSIDE RMB sodium nitroprusside 50mg/2mL concentrated injection vial

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

sodium nitroprusside, Quantity: 25 mg/mL

Verfügbar ab:

Southern XP IP Pty Ltd

Darreichungsform:

Injection, concentrated

Zusammensetzung:

Excipient Ingredients: water for injections

Verabreichungsweg:

Intravenous Infusion

Einheiten im Paket:

1 vial

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

NITROPRUSSIDE RMB concentrated injection is indicated for:,1. Immediate reduction of blood pressure in patients with hypertensive crises. Concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.,2. Producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.,3. Short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. Patients should be commenced on oral therapy as soon as possible.

Produktbesonderheiten:

Visual Identification: Clear reddish-brown solution in a 2 mL amber vial; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2022-11-14